Compare BSX & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | SAN |
|---|---|---|
| Founded | 1979 | 1857 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.7B | 152.1B |
| IPO Year | 1992 | 1987 |
| Metric | BSX | SAN |
|---|---|---|
| Price | $101.50 | $10.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 1 |
| Target Price | ★ $124.53 | N/A |
| AVG Volume (30 Days) | ★ 8.6M | 3.1M |
| Earning Date | 10-22-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | ★ 54.68 | 14.58 |
| EPS | ★ 1.87 | 1.00 |
| Revenue | $19,349,000,000.00 | ★ $59,455,590,761.00 |
| Revenue This Year | $21.04 | $23.32 |
| Revenue Next Year | $11.45 | N/A |
| P/E Ratio | $54.32 | ★ $10.73 |
| Revenue Growth | ★ 21.61 | 8.72 |
| 52 Week Low | $85.98 | $4.43 |
| 52 Week High | $109.50 | $11.13 |
| Indicator | BSX | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 59.58 |
| Support Level | $96.07 | $10.05 |
| Resistance Level | $101.77 | $10.42 |
| Average True Range (ATR) | 2.16 | 0.15 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 58.82 | 63.43 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.